Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2019
Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic CancerMariano Ponz-Sarvise, Vincenzo Corbo, Hervé Tiriac, et al.
Gut|April 26, 2024
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDACFrancesca Lupo, Francesco Pezzini, Davide Pasini, et al.
Gut|May 27, 2022
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancerMaria Chiara De Santis, Luca Gozzelino, Jean Piero Margaria, et al.
The Journal of Pathology|October 12, 2018
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreasEliana Amato, Andrea Mafficini, Kenichi Hirabayashi, et al.
Nature Communications|December 3, 2024
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancerLisa Veghini, Davide Pasini, Rui Fang, et al.
Immunity|May 15, 2024
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancerFrancesco De Sanctis, Silvia Dusi, Simone Caligola, et al.
Oncogene|August 13, 2022
Loss of FGFR4 promotes the malignant phenotype of PDACSabrina D'Agosto, Francesco Pezzini, Lisa Veghini, et al.
Human Pathology|July 22, 2018
PD-1, PD-L1, and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implicationsClaudio Luchini, Jerome Cros, Antonio Pea, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 2, 2022
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinomaAndrea Mafficini, Michele Simbolo, Tatsuhiro Shibata, et al.
Scientific Reports|February 22, 2017
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancerMichele Milella, Italia Falcone, Fabiana Conciatori, et al.
Pageof 11